ANI Pharmaceuticals Announces FDA Approval for Expansion of Iluvien Label

BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Iluvien (fluocinolone acetonide…Original Article